Day: September 22, 2022

LOS ANGELES CALIFORNIA, Sept. 22, 2022 (GLOBE NEWSWIRE) — MetAlert Inc. (OTC: GTXOD) formerly known as GTX Corp, a pioneer in the field of health & safety, wearable GPS human and asset tracking systems, and personal protective medical equipment, today announced its recent evolution and rebranding of the Company to reflect the broader vison centered around solutions that improve health, safety, wellness, longevity, and quality of life. The Company has a new name, updated logo, tagline and website www.metalert.com. Further, MetAlert effectuated a reverse stock split, a new CUSIP number and anticipates changing its ticker symbol in the coming weeks. “We are excited to be moving forward under the new MetAlert brand. The name GTX Corp no longer represents everything that we are doing or our vision of the future. In the beginning,...

Accomplished Operations Professional Promoted from Role as Director of Project Engineering; Credited with Leading All of the Company’s Ongoing Facility Expansion Projects TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the appointment of Michael Alston, Jr. as vice president, operations. Mr. Alston was promoted from Avid’s director of project engineering, a role in which he led all of the company’s ongoing facility expansions. In his new position, he will continue to oversee these projects including the Myford South expansion, as well as the construction...

YAVNE, Israel, Sept. 22, 2022 (GLOBE NEWSWIRE) — MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that it has entered into a definitive securities purchase agreement with several institutional and accredited investors (the “Registered Direct Securities Purchase Agreement”) for the sale and purchase of 7,575,513 shares of the Company’s ordinary shares, par value NIS 0.01 (the “Ordinary Shares”), at a purchase price of $1.75 per share, in a registered direct offering (the “Registered Direct Offering”). Additionally pursuant to the Registered Direct Securities Purchase Agreement, the Company has also agreed to issue to these investors unregistered warrants (the “Warrants”) to purchase up...

WARMINSTER, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will participate in a fireside chat at Chardan’s 6th Annual Genetic Medicines Conference taking place in New York on Tuesday, October 4, 2022 at 2:30 pm ET. Presenters: William Collier, President & Chief Executive Officer; Dr. Michael Sofia, Chief Scientific Offer; Dr. Gaston Picchio, Chief Development Officer; and David Hastings, Chief Financial Officer A live webcast of the fireside chat can be accessed through the Investors section of Arbutus’ website at www.arbutusbio.com. An archived replay of the webcast will be available on the Arbutus...

LAS VEGAS and VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) today announced its financial results for the three-month period ended July 31, 2022, its Fiscal Third Quarter of 2022 (referred to herein as “FQ3 2022”). A selection of highlights from the Company’s FQ3 2022 mandated filings is provided below. All monetary figures reported herein are in Canadian dollars unless specified otherwise. TAAT® Fiscal Third Quarter 2022 HighlightsRevenue of $17,473,223 resulting in a Gross Profit of $567,404 based on $16,905,819 as the Cost of Goods Sold; Growth of Total Assets to $23,383,865 reflecting an increase of 48.77% from the previous quarter, inclusive of $5,698,895 in Accounts Receivable and $5,119,919 in Inventory...

Figure 1 James Bay Geology – Midland ProjectsFigure 2 Mythril – Mythril Regional LocationMONTREAL, Sept. 22, 2022 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) solidified its land position on its Mythril and Mythril Regional Cu-Mo-Au-Ag projects (wholly owned by Midland) located in Eeyou Istchee James Bay, Quebec and is evaluating their lithium potential. Midland discovered the copper-gold mineral system Mythril by prospecting in late 2018 and concluded a strategic investment with BHP Billiton Canada Inc. (“BHP”) in the spring of 2019 totalling $5.85 million for copper exploration in Quebec. The Eeyou Istchee James Bay region is undergoing an exploration rush targeting lithium-bearing pegmatites. Mythril and Mythril Regional projects are strategically located 1.6 to 4.5 km north of the...

US$2 Million Purchase Order for 25 E-Motion™ 180E Powertrains MONTREAL, Sept. 22, 2022 (GLOBE NEWSWIRE) — Vision Marine Technologies, Inc. (Nasdaq: VMAR) (“Vision Marine” or the “Company”), the global leader in the performance electric recreational marine propulsion industry serving OEMs (Original Equipment Manufacturer), is pleased to announce an initial purchase order of 25 E-Motion™ 180E outboard motors and powertrain systems from The Limestone Boat Company (BOAT-TSXV). Limestone has a 35-year legacy as a North American “big water” brand known for its design, performance, quality, and durability. The company’s major brands consist of Aquasport, Limestone® and Boca Bay. This commitment by Limestone marks a significant turning point for Vision Marine, as this represents the Company’s first purchase order. The order comes on the...

Additional $3.5M of capital raised from exercise of expiring warrants LONDON, Ontario, Sept. 22, 2022 (GLOBE NEWSWIRE) — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE / XETRA:PSH), a clinical-stage company and leader in regenerative cell therapeutics, today announced that all remaining share purchase warrants related to the 2020 private placement, expiring on September 22, 2022, have been exercised with additional proceeds of $3.5M received since the Company’s last update on September 1, 2022. Capital raised through the exercise of these warrants will be directed to continued development of the Cell Pouch SystemTM and its application to ‘functional cures’ for diabetes, hypothyroidism and hemophilia A, as well as for general working capital purposes. “We believe the full exercise of all share purchase warrants with multiple expiry...

NEW YORK and CLEVELAND, Sept. 22, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Chief Executive Officer of Abeona, will participate in a fireside chat at the Jefferies Cell and Genetic Medicine Summit on Friday, September 30, 2022 at 8:30 a.m. ET. The Company will also participate in one-on-one investor meetings at the conference. A live webcast of the fireside chat will be available on the Investors section of the Abeona website under “Events” at https://investors.abeonatherapeutics.com/events. The webcast will be archived for 30 days. Those interested in attending the fireside chat or requesting a one-on-one meeting with Abeona are encouraged to contact their Jefferies representative. About Abeona Therapeutics Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical...

Davis/Paradise Property Location MapDavis/Paradise Property Target Map Showing Gold Values in Surface SamplingDavis/Paradise Property Target Map Showing Silver Values in Surface SamplingVANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to announce that it has received and compiled results from surface mapping and sampling of the Davis/Paradise project in Nevada conducted in April, May and June of this year. This more detailed sampling and mapping was focussed on areas identified and sampled in previous work on the project by Almadex and others. Almadex holds the rights to earn 100% of the Davis/Paradise property, which covers multiple targets, and is located approximately eight miles southeast of Gabbs, Nevada...